TAKEDA infusion vs. subcutaneous injection for Ulcerative Colitis study
This study is a 71 week study that will evaluate the effectiveness of study by infusion vs. subcutaneous injection.
Some general inclusion criteria are
- Diagnosis of UC established at lest 6 month prior to enrollment
- Must be willing to undergo endoscopy during screening period
- Has had previous treatment with TNF therapy without clinical response to treatment
- OR naïve to TNF therapy and currently failing current conventional treatment
Qualified Candidates May Receive
- Treatment By Liscensed GI Physician
- Study Paid Medication
- Compensation For Time And Travel
If you are interested in this trial, please call us at 816-318-8488, email us at info@ecrtrials.com, or complete the Volunteer Interest Form today.
